Observia
Michaël Thevenet has a strong background in technology and information systems management. Michaël is currently serving as the Chief Technology & Information Officer at Observia since August 2022. Prior to this, they held the position of Chief Technology Officer at Fidesio - Agence digitale from February to August 2022 and at myprm from August 2020 to February 2022. Michaël also served as the Head of Web Information System at Primaphot - Groupe Primavista from March 2019 to August 2020 and held various leadership roles in information systems and technology at Paritel, MRM//McCann, ENR'CERT, Evolutive Group, Come Out Group (ex-ANTHEA Interactive), and EOLEN.
From 2002 to 2004, Michaël Thevenet attended ITEVEC, where they pursued a Baccalauréat in Sciences et Technologies du Tertiaires with a focus on Actions et Communications Commerciales.
This person is not in any offices
Observia
Since 2011, we have been a passionate pioneering health tech company committed to driving the healthcare (r)evolution and improving patients’ lives. We work with healthcare stakeholders that aim to create value at every step of the patient journey: industrial companies, healthcare facilities, healthcare professionals, and patient organizations. As a European reference, we help companies to develop personalized, intelligent patient engagement and support solutions, and to define and implement patient strategies. We have created a new generation of evidence-based tools to support efficient patient behavioral change and improve the user experience. d.tells™, our smart engine for personalizing patient solutions, is powered by SPUR™, our behavioral diagnostic tool, and OPC™, our digital cloud platform that supports client’s developments. Our products are anchored in the behavioral sciences and driven by artificial intelligence, two critical pillars that promote effective personalization. These tools successfully help patients to overcome behavioral challenges, such as treatment non-adherence, and deliver clinically measurable results. Observia has been created in 2011 by three founders. After 3 years in Paris Biotech Santé incubator in Cochin hospital, Observia settled in Paris and opened a subsidiary in Shanghai in 2018. In 2021, the company employs more than 50 people and does 60% of its turnover internationally.